688189 ST南新
已收盘 09-04 15:00:01
资讯
新帖
简况
股市必读:ST南新新发布《2026年9月2日投资者关系活动记录表》
证券之星 · 01:33
股市必读:ST南新新发布《2026年9月2日投资者关系活动记录表》
每周股票复盘:ST南新(688189)转让应收款5175.67万元
证券之星 · 09-06 03:22
每周股票复盘:ST南新(688189)转让应收款5175.67万元
ST南新(688189)披露股东减持股份计划公告,9月2日股价下跌0.29%
证券之星 · 09-02
ST南新(688189)披露股东减持股份计划公告,9月2日股价下跌0.29%
ST南新(688189.SH):广州乾元拟减持不超3%股份
智通财经 · 09-02
ST南新(688189.SH):广州乾元拟减持不超3%股份
ST南新(688189)披露2026年半年度报告,8月31日股价上涨1.81%
证券之星 · 08-31
ST南新(688189)披露2026年半年度报告,8月31日股价上涨1.81%
ST南新:聘任彭程先生为公司总经理
证券之星 · 08-31
ST南新:聘任彭程先生为公司总经理
ST南新:截至2026年8月20日,公司股东总户数为8873户
证券之星 · 08-31
ST南新:截至2026年8月20日,公司股东总户数为8873户
ST南新2026年半年报:新药研发获进展,亏损幅度收窄
蓝鲸财经 · 08-31
ST南新2026年半年报:新药研发获进展,亏损幅度收窄
图解ST南新中报:第二季度单季净利润同比增长25.20%
证券之星 · 08-30
图解ST南新中报:第二季度单季净利润同比增长25.20%
ST南新(688189)6月30日股东户数0.9万户,较上期减少28.82%
证券之星 · 08-30
ST南新(688189)6月30日股东户数0.9万户,较上期减少28.82%
ST南新(688189.SH):上半年净亏损3716.17万元
中金财经 · 08-30
ST南新(688189.SH):上半年净亏损3716.17万元
每周股票复盘:ST南新(688189)将举办半年度业绩说明会
证券之星 · 08-30
每周股票复盘:ST南新(688189)将举办半年度业绩说明会
股市必读:ST南新新发布《关于参加2026年湖南辖区上市公司投资者网上集体接待日暨半年度业绩说明会活动的公告》
证券之星 · 08-26
股市必读:ST南新新发布《关于参加2026年湖南辖区上市公司投资者网上集体接待日暨半年度业绩说明会活动的公告》
ST南新(688189)披露聘任总经理公告,8月24日股价下跌2.31%
证券之星 · 08-24
ST南新(688189)披露聘任总经理公告,8月24日股价下跌2.31%
破发股ST南新跌2.74% 2020年上市募12亿西部证券保荐
中金财经 · 08-18
破发股ST南新跌2.74% 2020年上市募12亿西部证券保荐
每周股票复盘:ST南新(688189)因信披违规被公开谴责
证券之星 · 08-16
每周股票复盘:ST南新(688189)因信披违规被公开谴责
ST南新因信息披露违规等违规行为被证监会出具警示函
证券之星 · 08-14
ST南新因信息披露违规等违规行为被证监会出具警示函
ST南新(688189)披露关于减少注册资本、修订《公司章程》并完成工商变更登记的公告,8月10日股价上涨1.79%
证券之星 · 08-10
ST南新(688189)披露关于减少注册资本、修订《公司章程》并完成工商变更登记的公告,8月10日股价上涨1.79%
股市必读:ST南新(688189)7月31日董秘有最新回复
证券之星 · 08-03
股市必读:ST南新(688189)7月31日董秘有最新回复
股市必读:ST南新(688189)7月30日董秘有最新回复
证券之星 · 07-31
股市必读:ST南新(688189)7月30日董秘有最新回复
加载更多
公司概况
公司名称:
湖南南新制药股份有限公司
所属行业:
医药制造业
上市日期:
2020-03-26
主营业务:
湖南南新制药股份有限公司的主营业务是抗感染、呼吸系统和心脑血管等疾病领域药品的研发、生产与销售。公司的主要产品是帕拉米韦氯化钠注射液、磷酸奥司他韦干混悬剂、辛伐他汀分散片、阿托伐他汀钙片、贝那普利氢氯噻嗪片、头孢呋辛酯分散片、头孢克洛胶囊、头孢克洛干混悬剂、乳酸环丙沙星氯化钠注射液、布洛芬混悬滴剂、布洛芬混悬液、盐酸美金刚缓释胶囊。
发行价格:
34.94
{"stockData":{"symbol":"688189","market":"SH","secType":"STK","nameCN":"ST南新","latestPrice":6.71,"timestamp":1788505201000,"preClose":6.71,"halted":0,"volume":3228629,"delay":0,"changeRate":0,"floatShares":273000000,"shares":273000000,"eps":-0.4914,"marketStatus":"已收盘","change":0,"latestTime":"09-04 15:00:01","open":6.73,"high":6.83,"low":6.68,"amount":21762300,"amplitude":0.0224,"askPrice":6.73,"askSize":100,"bidPrice":6.71,"bidSize":306,"shortable":0,"etf":0,"ttmEps":-0.4914,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1788744600000},"marketStatusCode":5,"adr":0,"adjPreClose":6.71,"symbolType":"stock_kcb","openAndCloseTimeList":[[1788485400000,1788492600000],[1788498000000,1788505200000]],"highLimit":7.05,"lowLimit":6.37,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":272829414,"isCdr":false,"pbRate":2.35,"roa":"--","roe":"--","epsLYR":-0.4989,"committee":0.241445,"marketValue":1831000000,"turnoverRate":0.0118,"status":2,"afterMarket":{"amount":0,"volume":0,"close":6.71,"buyVolume":40000,"sellVolume":0,"time":1788507237746,"indexStatus":"已收盘 09-04 15:30:00","preClose":6.71},"floatMarketCap":1831000000},"requestUrl":"/m/hq/s/688189","defaultTab":"news","newsList":[{"id":"2665367857","title":"股市必读:ST南新新发布《2026年9月2日投资者关系活动记录表》","url":"https://stock-news.laohu8.com/highlight/detail?id=2665367857","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665367857?lang=zh_cn&edition=full","pubTime":"2026-09-07 01:33","pubTimestamp":1788715988,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘,ST南新报收于6.71元,上涨0.0%,换手率1.18%,成交量3.23万手,成交额2176.23万元。当日关注点交易信息汇总:9月4日主力资金净流入101.59万元,占总成交额4.67%。公司公告汇总:帕拉米韦吸入溶液III期临床已达主要终点,正推进上市申报前沟通,预计审核周期12–18个月。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090700000785.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688189","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665366568","title":"每周股票复盘:ST南新(688189)转让应收款5175.67万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2665366568","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665366568?lang=zh_cn&edition=full","pubTime":"2026-09-06 03:22","pubTimestamp":1788636131,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘,ST南新报收于6.71元,较上周的6.62元上涨1.36%。本周,ST南新9月2日盘中最高价报6.96元。本周关注点来自公司公告汇总:公司转让部分应收账款给控股股东,收回转让款5175.67万元。公司通过公开挂牌程序,将部分应收账款转让给控股股东湖南医药发展投资集团有限公司,转让价款为5,175.67万元。控股股东已全额支付应收账款转让款5175.67万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090600001120.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664810788","title":"ST南新(688189)披露股东减持股份计划公告,9月2日股价下跌0.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664810788","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664810788?lang=zh_cn&edition=full","pubTime":"2026-09-02 23:04","pubTimestamp":1788361465,"startTime":"0","endTime":"0","summary":"截至2026年9月2日收盘,ST南新报收于6.86元,较前一交易日下跌0.29%,最新总市值为18.72亿元。近日,ST南新披露《股东减持股份计划公告》。公告显示,截至2026年9月3日,公司股东广州乾元持有公司股份43,120,000股,占总股本的15.80%。因资金需求,广州乾元拟于2026年9月28日至12月25日期间,通过集中竞价和大宗交易方式减持不超过8,184,882股,即不超过公司总股本的3.00%。本次减持计划不会导致公司控制权变更。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090200043482.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688189","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664890748","title":"ST南新(688189.SH):广州乾元拟减持不超3%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2664890748","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664890748?lang=zh_cn&edition=full","pubTime":"2026-09-02 17:36","pubTimestamp":1788341789,"startTime":"0","endTime":"0","summary":"智通财经APP讯,ST南新(688189.SH)发布公告,因资金需求,广州乾元投资咨询合伙企业(有限合伙)(简称“广州乾元”)拟通过集中竞价交易和大宗交易方式减持其所持有的公司股份,在减持计划披露之日起十五个交易日后的三个月内进行,合计减持股份数量不超过818.49万股,不超过公司总股本的3%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490994.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688189","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663709930","title":"ST南新(688189)披露2026年半年度报告,8月31日股价上涨1.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663709930","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663709930?lang=zh_cn&edition=full","pubTime":"2026-08-31 19:29","pubTimestamp":1788175784,"startTime":"0","endTime":"0","summary":"截至2026年8月31日收盘,ST南新报收于6.74元,较前一交易日上涨1.81%,最新总市值为18.39亿元。公司于近日披露《2026年半年度报告》。公告显示,湖南南新制药股份有限公司2026年半年度报告摘要中,公司总资产为854,407,608.70元,较上年度末增长5.55%;归属于上市公司股东的净资产为780,521,594.01元,较上年度末减少0.39%。本期营业收入为56,044,691.74元,同比下降9.38%;利润总额为-40,993,615.57元,归属于上市公司股东的净利润为-37,161,656.58元,亏损同比收窄。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100031207.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663789580","title":"ST南新:聘任彭程先生为公司总经理","url":"https://stock-news.laohu8.com/highlight/detail?id=2663789580","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663789580?lang=zh_cn&edition=full","pubTime":"2026-08-31 15:33","pubTimestamp":1788161625,"startTime":"0","endTime":"0","summary":"证券之星消息,ST南新(688189)08月31日在投资者关系平台上答复投资者关心的问题。投资者提问:你好,公司近期人事是否有变动?ST南新回复:尊敬的投资者您好,公司近期完成总经理聘任工作,经董事会审议通过,聘任彭程先生为公司总经理,相关事项已对外披露。本次属于公司正常经营层面人事安排,不会对公司生产经营产生不利影响,管理层相关信息请以公司公开公告为准。感谢关注!本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。责任编辑:陈思雨","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100015539.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688189","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663786040","title":"ST南新:截至2026年8月20日,公司股东总户数为8873户","url":"https://stock-news.laohu8.com/highlight/detail?id=2663786040","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663786040?lang=zh_cn&edition=full","pubTime":"2026-08-31 15:33","pubTimestamp":1788161625,"startTime":"0","endTime":"0","summary":"证券之星消息,ST南新(688189)08月31日在投资者关系平台上答复投资者关心的问题。投资者提问:请问截止8月20日,股东户数是多少?谢谢!ST南新回复:尊敬的投资者您好,根据中国证券登记结算有限责任公司提供的数据,截至2026年8月20日,公司股东总户数为8873户。感谢您的关注!本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。责任编辑:陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100015537.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663602973","title":"ST南新2026年半年报:新药研发获进展,亏损幅度收窄","url":"https://stock-news.laohu8.com/highlight/detail?id=2663602973","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663602973?lang=zh_cn&edition=full","pubTime":"2026-08-31 11:13","pubTimestamp":1788146034,"startTime":"0","endTime":"0","summary":"蓝鲸新闻8月31日讯,8月30日,ST南新 公布2026年中报,公司依托抗感染与呼吸系统领域核心产品,受制于医药行业集采深化及市场竞争加剧,报告期业绩持续承压但亏损幅度收窄;同时,改良型新药研发取得里程碑进展,并通过向控股股东转让应收账款优化资产结构。截至报告期末,公司总资产8.54亿元,较上年度末增长5.55%,主要系新增银行贷款及往来款项增加。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1788143016716096258","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["688189","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663049078","title":"图解ST南新中报:第二季度单季净利润同比增长25.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663049078","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663049078?lang=zh_cn&edition=full","pubTime":"2026-08-30 17:39","pubTimestamp":1788082795,"startTime":"0","endTime":"0","summary":"证券之星消息,ST南新2026年中报显示,上半年度公司主营收入5604.47万元,同比下降9.38%;归母净利润-3716.17万元,同比上升7.1%;扣非净利润-3586.34万元,同比上升14.06%;其中2026年第二季度,公司单季度主营收入2999.58万元,同比上升41.35%;单季度归母净利润-2391.81万元,同比上升25.2%;单季度扣非净利润-2241.11万元,同比上升32.99%;负债率16.91%,财务费用-35.98万元,毛利率15.0%。财报数据概要请见下图:本文数据来源于ST南新2026年中报,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000012890.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663494260","title":"ST南新(688189)6月30日股东户数0.9万户,较上期减少28.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663494260","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663494260?lang=zh_cn&edition=full","pubTime":"2026-08-30 17:07","pubTimestamp":1788080867,"startTime":"0","endTime":"0","summary":"证券之星消息,近日ST南新披露,截至2026年6月30日公司股东户数为9021.0户,较3月31日减少3652.0户,减幅为28.82%。在化学制药行业个股中,ST南新股东户数低于行业平均水平,截至6月30日,化学制药行业平均股东户数为3.67万户。从股价来看,2026年3月31日至2026年6月30日,ST南新区间跌幅为21.83%,在此期间股东户数减少3652.0户,减幅为28.82%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000011115.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663049512","title":"ST南新(688189.SH):上半年净亏损3716.17万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2663049512","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663049512?lang=zh_cn&edition=full","pubTime":"2026-08-30 16:27","pubTimestamp":1788078423,"startTime":"0","endTime":"0","summary":"格隆汇8月30日丨ST南新(688189.SH)发布2026年半年度报告,报告期内,实现营业收入5604.47万元,同比减少9.38%;归属于上市公司股东的净利润-3716.17万元,上年同期归属于上市公司股东的净利润-4000.23万元;归属于上市公司股东的扣除非经常性损益的净利润-3586.34万元,上年同期归属于上市公司股东的扣除非经常性损益的净利润-4173.14万元;基本每股收益-0.1354元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260830/32353731.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0239","688189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663004334","title":"每周股票复盘:ST南新(688189)将举办半年度业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2663004334","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663004334?lang=zh_cn&edition=full","pubTime":"2026-08-30 06:52","pubTimestamp":1788043931,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘,ST南新报收于6.62元,较上周的6.5元上涨1.85%。本周,ST南新8月28日盘中最高价报6.71元。ST南新当前最新总市值18.06亿元,在化学制药板块市值排名149/149,在两市A股市值排名5142/5211。本周关注点公司公告汇总:湖南南新制药将参加2026年湖南辖区上市公司投资者网上集体接待日暨半年度业绩说明会活动。活动时间为2026年9月2日14:30-17:00,公司高级管理人员将就2025年至2026年半年度业绩、公司治理、发展战略、经营状况等与投资者进行交流。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000003607.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662769868","title":"股市必读:ST南新新发布《关于参加2026年湖南辖区上市公司投资者网上集体接待日暨半年度业绩说明会活动的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2662769868","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662769868?lang=zh_cn&edition=full","pubTime":"2026-08-26 09:45","pubTimestamp":1787708750,"startTime":"0","endTime":"0","summary":"公司公告汇总关于参加2026年湖南辖区上市公司投资者网上集体接待日暨半年度业绩说明会活动的公告湖南南新制药股份有限公司将参加由湖南证监局、湖南省上市公司协会与深圳市全景网络有限公司联合举办的2026年湖南辖区上市公司投资者网上集体接待日暨半年度业绩说明会活动。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600017552.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661220481","title":"ST南新(688189)披露聘任总经理公告,8月24日股价下跌2.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661220481","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661220481?lang=zh_cn&edition=full","pubTime":"2026-08-24 18:13","pubTimestamp":1787566397,"startTime":"0","endTime":"0","summary":"截至2026年8月24日收盘,ST南新报收于6.35元,较前一交易日下跌2.31%,最新总市值为17.32亿元。公司于近日披露《关于聘任总经理的公告》。公告显示,湖南南新制药股份有限公司于2026年8月21日召开第二届董事会第二十四次会议,审议通过《关于聘任公司总经理的议案》,同意聘任彭程先生为公司总经理,任期自董事会审议通过之日起至本届董事会换届选举完成之日止。彭程先生间接持有公司股份1,263,721股,占总股本的0.46%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400026042.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660845004","title":"破发股ST南新跌2.74% 2020年上市募12亿西部证券保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2660845004","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660845004?lang=zh_cn&edition=full","pubTime":"2026-08-18 16:03","pubTimestamp":1787040181,"startTime":"0","endTime":"0","summary":"中国经济网北京8月18日讯 ST南新 今日收报6.74元,跌幅2.74%。目前该股处于破发状态。A股股票简称由“南新制药”变更为“ST南新”;扩位简称由“南新制药”变更为“ST南新制药”,实施其他风险警示的起始日为2026年6月11日。 南新制药于2020年3月26日在上交所科创板上市,发行价格为34.94元/股,首次公开发行新股3500万股,保荐机构为西部证券股份有限公司,保荐代表人为李锋、邹扬。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260818/32338479.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0183","BK0028","688189","BK0239","BK0276","002673","BK0188","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659117618","title":"每周股票复盘:ST南新(688189)因信披违规被公开谴责","url":"https://stock-news.laohu8.com/highlight/detail?id=2659117618","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659117618?lang=zh_cn&edition=full","pubTime":"2026-08-16 03:19","pubTimestamp":1786821550,"startTime":"0","endTime":"0","summary":"截至2026年8月14日收盘,ST南新报收于6.93元,较上周的6.71元上涨3.28%。本周关注点监管公告:ST南新及多名高管因信息披露违规被上交所公开谴责。湖南南新制药股份有限公司于2026年8月13日收到中国证券监督管理委员会湖南监管局出具的警示函。监管公告8月13日ST南新公开信息显示,湖南南新制药股份有限公司,董事长张世喜、李亮、胡新保因信息披露违规,涉嫌违反证券法律法规,未依法履行其他职责被上海证券交易所公开谴责。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081600000976.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688189"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659169993","title":"ST南新因信息披露违规等违规行为被证监会出具警示函","url":"https://stock-news.laohu8.com/highlight/detail?id=2659169993","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659169993?lang=zh_cn&edition=full","pubTime":"2026-08-14 01:00","pubTimestamp":1786640453,"startTime":"0","endTime":"0","summary":"证券之星消息,8月14日ST南新公开信息显示,湖南南新制药股份有限公司,董事长张世喜、杨文逊、李亮、胡新保因信息披露违规,未依法履行其他职责被中国证券监督管理委员会湖南监管局出具警示函。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081400000743.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688189","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658378499","title":"ST南新(688189)披露关于减少注册资本、修订《公司章程》并完成工商变更登记的公告,8月10日股价上涨1.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658378499","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658378499?lang=zh_cn&edition=full","pubTime":"2026-08-10 22:40","pubTimestamp":1786372825,"startTime":"0","endTime":"0","summary":"近日,湖南南新制药股份有限公司发布《关于减少注册资本、修订〈公司章程〉并完成工商变更登记的公告》。公告显示,公司于2026年4月28日和5月22日分别召开第二届董事会第二十三次会议及2025年年度股东会,审议通过了关于变更回购股份用途并注销暨减少注册资本并修订《公司章程》的议案。公司已办理完毕工商变更登记及《公司章程》备案手续,并取得湖南省市场监督管理局换发的营业执照。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000034518.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688189","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656343676","title":"股市必读:ST南新(688189)7月31日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2656343676","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656343676?lang=zh_cn&edition=full","pubTime":"2026-08-03 02:57","pubTimestamp":1785697028,"startTime":"0","endTime":"0","summary":"截至2026年7月31日收盘,ST南新报收于6.39元,上涨2.24%,换手率1.47%,成交量4.01万手,成交额2559.32万元。董秘最新回复投资者: 你好,公司的网络销售渠道与院外市场开拓的怎么样了?院外市场选取重点省份开展商控渠道试点,积极拓展药店、基层诊所等终端,试点逐步形成销售增量。两大新兴渠道均取得阶段性进展并贡献收入,但仍处于培育期。当日关注点交易信息汇总:7月31日主力资金净流出170.47万元,占总成交额6.66%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300001156.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688189","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655662800","title":"股市必读:ST南新(688189)7月30日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2655662800","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655662800?lang=zh_cn&edition=full","pubTime":"2026-07-31 02:24","pubTimestamp":1785435855,"startTime":"0","endTime":"0","summary":"截至2026年7月30日收盘,ST南新报收于6.25元,下跌4.29%,换手率1.94%,成交量5.29万手,成交额3362.38万元。董秘最新回复投资者: 你好,新《医疗保障基金监督检查五年行动计划》和《处方药网络零售合规指南》对公司的积极和消极影响有哪些?公司持续跟进政策实施进展,完善内控合规体系。相关政策影响存在不确定性,敬请注意投资风险。当日关注点交易信息汇总:7月30日主力资金净流出148.05万元,占总成交额4.4%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026073100001778.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688189","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1788721403840,"stockEarnings":[{"period":"1week","weight":0.0136},{"period":"1month","weight":0.0387},{"period":"3month","weight":-0.1331},{"period":"6month","weight":-0.1767},{"period":"1year","weight":-0.4943},{"period":"ytd","weight":-0.1581}],"compareEarnings":[{"period":"1week","weight":-0.0056},{"period":"1month","weight":0.0133},{"period":"3month","weight":-0.0242},{"period":"6month","weight":-0.0471},{"period":"1year","weight":0.0436},{"period":"ytd","weight":-0.0098}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"湖南南新制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"8873人(较上一季度减少1.64%)","perCapita":"30748股","listingDate":"2020-03-26","address":"湖南省长沙市浏阳市经济技术开发区康里路1号","registeredCapital":"27282万元","survey":" 湖南南新制药股份有限公司的主营业务是抗感染、呼吸系统和心脑血管等疾病领域药品的研发、生产与销售。公司的主要产品是帕拉米韦氯化钠注射液、磷酸奥司他韦干混悬剂、辛伐他汀分散片、阿托伐他汀钙片、贝那普利氢氯噻嗪片、头孢呋辛酯分散片、头孢克洛胶囊、头孢克洛干混悬剂、乳酸环丙沙星氯化钠注射液、布洛芬混悬滴剂、布洛芬混悬液、盐酸美金刚缓释胶囊。","listedPrice":34.94},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ST南新(688189)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ST南新(688189)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ST南新,688189,ST南新股票,ST南新股票老虎,ST南新股票老虎国际,ST南新行情,ST南新股票行情,ST南新股价,ST南新股市,ST南新股票价格,ST南新股票交易,ST南新股票购买,ST南新股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ST南新(688189)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ST南新(688189)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}